Extendicare (TSE:EXE) PT Set at C$15.40 by National Bankshares

Extendicare (TSE:EXEGet Free Report) received a C$15.40 price target from National Bankshares in a research report issued to clients and investors on Thursday,BayStreet.CA reports. The brokerage currently has an “outperform” rating on the stock. National Bankshares’ price target would suggest a potential upside of 19.29% from the stock’s current price.

A number of other equities research analysts have also weighed in on EXE. BMO Capital Markets lifted their price objective on shares of Extendicare from C$13.50 to C$14.50 in a report on Monday, May 12th. TD Securities lifted their price target on Extendicare from C$13.00 to C$15.00 and gave the company a “hold” rating in a report on Thursday, May 22nd. Three research analysts have rated the stock with a hold rating, one has assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, Extendicare presently has a consensus rating of “Moderate Buy” and an average price target of C$13.98.

Get Our Latest Report on EXE

Extendicare Trading Down 2.4%

Shares of TSE EXE opened at C$12.91 on Thursday. Extendicare has a fifty-two week low of C$7.34 and a fifty-two week high of C$15.24. The company has a debt-to-equity ratio of 283.02, a quick ratio of 0.98 and a current ratio of 0.62. The company has a market cap of C$1.08 billion, a price-to-earnings ratio of 16.46 and a beta of 1.26. The business’s 50 day moving average price is C$14.03 and its 200-day moving average price is C$12.76.

Extendicare Company Profile

(Get Free Report)

Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.

Further Reading

Analyst Recommendations for Extendicare (TSE:EXE)

Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.